Trial Profile
Indacaterol Mono- and Combination Therapy with Inhaled Tiotropium Bromide in COPD: A 52-Week Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2015
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 14 Aug 2015 New trial record